New insights into the genetics of fibromyalgia

키워드

참고문헌 (82)

1. Jakobsson U., "The epidemiology of chronic pain in a general population: results of a survey in southern Sweden", Scand J Rheumatol, 39, pp.421~429 (2010)
2. Jones GT, "The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria", Arthritis Rheumatol, 67, pp.568~575 (2015)
3. 최덕현, "Quantitative analysis of nailfold capillary morphology in patients with fibromyalgia", The Korean Journal of Internal Medicine, 30(4), pp.531~537 (2015), 대한내과학회[DOI]
4. Chang-Nam Son, "A neurometabolite study of chronic daily headache in patients with systemic lupus erythematosus using magnetic resonance spectroscopy: comparison with fibromyalgia patients and healthy controls", The Korean Journal of Internal Medicine, 31(6), pp.1171~1177 (2016), 대한내과학회[DOI]
5. Wolfe F, "The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity", Arthritis Care Res (Hoboken), 62, pp.600~610 (2010)
6. Kim SK, "Effect of fibromyalgia syndrome on the health-related quality of life and economic burden in Korea", Rheumatology (Oxford), 52, pp.311~320 (2013)
7. Doron Y, "The clinical and economic burden of fibromyalgia compared with diabetes mellitus and hypertension among Bedouin women in the Negev", Fam Pract, 21, pp.415~419 (2004)
8. Spaeth M., "Epidemiology, costs, and the economic burden of fibromyalgia", Arthritis Res Ther, 11, pp.117~ (2009)
9. Clauw DJ., "Fibromyalgia: a clinical review", JAMA, 311, pp.1547~1555 (2014)
10. Staud R, "Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome", Pain, 91, pp.165~175 (2001)
11. Abeles AM, "Narrative review: the pathophysiology of fibromyalgia", Ann Intern Med, 146, pp.726~734 (2007)
12. Mogil JS., "Pain genetics: past, present and future", Trends Genet, 28, pp.258~266 (2012)
13. Hocking LJ, "Heritability of chronic pain in 2195 extended families", Eur J Pain, 16, pp.1053~1063 (2012)
14. Oertel B, "Genetic mutations that prevent pain:implications for future pain medication", Pharmacogenomics, 9, pp.179~194 (2008)
15. LaCroix-Fralish ML, "Patterns of pain: meta-analysis of microarray studies of pain", Pain, 152, pp.1888~1898 (2011)
16. Buskila D, "Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome", Arthritis Res Ther, 8, pp.218~ (2006)
17. Pellegrino MJ, "Familial occurrence of primary fibromyalgia", Arch Phys Med Rehabil, 70, pp.61~63 (1989)
18. Buskila D, "Familial aggregation in the fibromyalgia syndrome", Semin Arthritis Rheum, 26, pp.605~611 (1996)
19. Buskila D, "Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM", J Rheumatol, 24, pp.941~944 (1997)
20. Arnold LM, "Family study of fibromyalgia", Arthritis Rheum, 50, pp.944~952 (2004)
21. Arnold LM, "The fibromyalgia family study: a genome-wide linkage scan study", Arthritis Rheum, 65, pp.1122~1128 (2013)
22. Glazer Y, "Differences in the personality profile of fibromyalgia patients and their relatives with and without fibromyalgia", Clin Exp Rheumatol, 28(6 Suppl 63), pp.S27~S32 (2010)
23. Norrgard K., "Genetic variation and disease: GWAS", Nat Educ, 1, pp.87~ (2008)
24. Feng J, "Discovery of potential new gene variants and inflammatory cytokine associations with fibromyalgia syndrome by whole exome sequencing", PLoS One, 8, pp.e65033~ (2013)
25. Docampo E, "Genomewide analysis of single nucleotide polymorphisms and copy number variants in fibromyalgia suggest a role for the central nervous system", Pain, 155, pp.1102~1109 (2014)
26. Peters MJ, "Genome-wide association study meta-analysis of chronic widespread pain: evidence for involvement of the 5p15.2 region", Ann Rheum Dis, 72, pp.427~436 (2013)
27. Dawn Teare M, "Genetic linkage studies", Lancet, 366, pp.1036~1044 (2005)
28. Russell IJ, "Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia", fibrositis syndrome, 1992, pp.19, 104~109
29. Russell IJ, "Cerebrospinal fluid biogenic amine metabolites in fibromyalgia", fibrositis syndrome and rheumatoid arthritis, 1992, pp.35, 550~556
30. Wolfe F, "Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population", J Rheumatol, 24, pp.555~559 (1997)
31. Eison AS, "Regulation of central 5-HT2A receptors: a review of in vivo studies", Behav Brain Res, 73, pp.177~181 (1996)
32. Kuzelova H, "The serotonin transporter gene (5-HTT) variant and psychiatric disorders: review of current literature", Neuro Endocrinol Lett, 31, pp.4~10 (2010)
33. Bondy B, "The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia", Neurobiol Dis, 6, pp.433~439 (1999)
34. Mergener M, "Influence of the interaction between environmental quality and T102C SNP in the HTR2A gene on fibromyalgia susceptibility", Rev Bras Reumatol, 51, pp.594~602 (2011)
35. Gursoy S, "Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome", Rheumatol Int, 21, pp.58~61 (2001)
36. Tander B, "Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility", Rheumatol Int, 28, pp.685~691 (2008)
37. Lee YH, "Candidate gene studies of fibromyalgia: a systematic review and meta-analysis", Rheumatol Int, 32, pp.417~426 (2012)
38. Frank B, "Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients", Clin Rheumatol, 23, pp.338~344 (2004)
39. Offenbaecher M, "Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region", Arthritis Rheum, 42, pp.2482~2488 (1999)
40. Cohen H, "Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR)polymorphism, and relationship to anxiety-related personality traits", Arthritis Rheum, 46, pp.845~847 (2002)
41. Gursoy S., "Absence of association of the serotonin transporter gene polymorphism with the mentally healthy subset of fibromyalgia patients", Clin Rheumatol, 21, pp.194~197 (2002)
42. Haus U, "Oral treatment of fibromyalgia with tropisetron given over 28days: influence on functional and vegetative symptoms, psychometric parameters and pain", Scand J Rheumatol Suppl, 113, pp.55~58 (2000)
43. Hrycaj P, "Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome: a preliminary study", J Rheumatol, 23, pp.1418~1423 (1996)
44. Murphy DL, "Brain serotonin neurotransmission:an overview and update with an emphasis on serotonin subsystem heterogeneity, multiple receptors, interactions with other neurotransmitter systems, and consequent implications for understanding the actions of serotonergic drugs", J Clin Psychiatry, 59(Suppl 15), pp.4~12 (1998)
45. Matsumoto M, "Catechol Omethyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function", Neuroscience, 116, pp.127~137 (2003)
46. Zubieta JK, "COMT val-158met genotype affects mu-opioid neurotransmitter responses to a pain stressor", Science, 299, pp.1240~1243 (2003)
47. Lachman HM, "Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders", Pharmacogenetics, 6, pp.243~250 (1996)
48. Matsuda JB, "Serotonin receptor (5-HT 2A) and catechol-O-methyltransferase (COMT)gene polymorphisms: triggers of fibromyalgia?", Rev Bras Reumatol, 50, pp.141~149 (2010)
49. Barbosa FR, "Influence of catechol-O-methyltransferase (COMT) gene polymorphisms in pain sensibility of Brazilian fibromialgia patients", Rheumatol Int, 32, pp.427~430 (2012)
50. Vargas-Alarcon G, "Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia", Arthritis Res Ther, 9, pp.R110~ (2007)
51. Gursoy S, "Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome", Rheumatol Int, 23, pp.104~107 (2003)
52. Cohen H, "The relationship between a common catechol-Omethyltransferase (COMT) polymorphism val(158) met and fibromyalgia", Clin Exp Rheumatol, 27(5 Suppl 56), pp.S51~S56 (2009)
53. Martinez-Jauand M, "Pain sensitivity in fibromyalgia is associated with catechol-Omethyltransferase (COMT) gene", Eur J Pain, 17, pp.16~27 (2013)
54. Finan PH, "COMT moderates the relation of daily maladaptive coping and pain in fibromyalgia", Pain, 152, pp.300~307 (2011)
55. Potvin S, "DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls", J Pain, 10, pp.969~975 (2009)
56. Park DJ, "Association between catechol-O-methyl transferase gene polymorphisms and fibromyalgia in a Korean population: a case-control study", Eur J Pain, 20, pp.1131~1139 (2016)
57. Lee YH, "Association between the COMT Val158Met polymorphism and fibromyalgia susceptibility and fibromyalgia impact questionnaire score:a meta-analysis", Rheumatol Int, 35, pp.159~166 (2015)
58. Zhang L, "Meta-analysis reveals a lack of association between a common catechol-O-methyltransferase (COMT) polymorphism val15 8met and fibromyalgia", Int J Clin Exp Pathol, 7, pp.8489~8497 (2014)
59. Diatchenko L, "Catechol-Omethyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli", Pain, 125, pp.216~224 (2006)
60. Jarcho JM, "Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction", Pain, 153, pp.744~754 (2012)
61. Wood PB., "Role of central dopamine in pain and analgesia", Expert Rev Neurother, 8, pp.781~797 (2008)
62. Malt EA, "Altered dopamine D2 receptor function in fibromyalgia patients:a neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls", J Affect Disord, 75, pp.77~82 (2003)
63. Wood PB, "Fibromyalgia patients show an abnormal dopamine response to pain", Eur J Neurosci, 25, pp.3576~3582 (2007)
64. Holman AJ, "A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications", Arthritis Rheum, 52, pp.2495~2505 (2005)
65. Buskila D, "An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits", Mol Psychiatry, 9, pp.730~731 (2004)
66. Park DJ, "Polymorphisms of the TRPV2 and TRPV3 genes associated with fibromyalgia in a Korean population", Rheumatology (Oxford), 55, pp.1518~1527 (2016)
67. Kim SK, "Association of guanosine triphosphate cyclohydrolase 1 gene polymorphisms with fibromyalgia syndrome in a Korean population", J Rheumatol, 40, pp.316~322 (2013)
68. Thony B, "Tetrahydrobiopterin biosynthesis, regeneration and functions", Biochem J, 347(Pt 1), pp.1~16 (2000)
69. Tegeder I, "GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence", Nat Med, 12, pp.1269~1277 (2006)
70. Larson AA, "Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia:implications for nitric oxide pathways", Pain, 87, pp.201~211 (2000)
71. Groth R, "Spinal brain-derived neurotrophic factor (BDNF) produces hyperalgesia in normal mice while antisense directed against either BDNF or trkB, prevent inflammation-induced hyperalgesia", Pain, 100, pp.171~181 (2002)
72. Kerr BJ, "Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord", J Neurosci, 19, pp.5138~5148 (1999)
73. Juhasz G, "The CREB1-BDNFNTRK2pathway in depression: multiple gene-cognitionenvironment interactions", Biol Psychiatry, 69, pp.762~771 (2011)
74. Murphy GM Jr, "BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression", Pharmacogenet Genomics, 23, pp.301~313 (2013)
75. Smith SB, "Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia", Arthritis Rheum, 64, pp.584~593 (2012)
76. Eglen RM, "Ions in the fire: recent ionchannel research and approaches to pain therapy", Trends Pharmacol Sci, 20, pp.337~342 (1999)
77. Dib-Hajj SD, "Sodium channels in normal and pathological pain", Annu Rev Neurosci, 33, pp.325~347 (2010)
78. Vargas-Alarcon G, "A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia", BMC Musculoskelet Disord, 13, pp.23~ (2012)
79. Vargas-Alarcon G, "Association of adrenergic receptor gene polymorphisms with different fibromyalgia syndrome domains", Arthritis Rheum, 60, pp.2169~2173 (2009)
80. Small KM, "Pharmacology and physiology of human adrenergic receptor polymorphisms", Annu Rev Pharmacol Toxicol, 43, pp.381~411 (2003)
81. Bjersing JL, "Profile of cerebrospinal microRNAs in fibromyalgia", PLoS One, 8, pp.e78762~ (2013)
82. Bjersing JL, "Profile of circulating microRNAs in fibromyalgia and their relation to symptom severity: an exploratory study", Rheumatol Int, 35, pp.635~642 (2015)

관련 논문AI추천